About The Study: This randomized clinical trial found that treatment with abatacept, cenicriviroc, or infliximab showed no significant difference of time to recovery compared with placebo for patients hospitalized with COVID-19 pneumonia.
Authors: William G. Powderly, M.D., of the Washington University School of Medicine in St. Louis, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.11043?guestAccessKey=b2d402d1-9027-49c8-9410-0cd186909528&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071023